Price $13.75 |
Market Cap
618.3M
|
Sector Health Care |
Div. Growth
-18.80%
|
|
P/E
27.6
|
P/B
-
|
P/S
-
|
Dividend %
3.60%
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-
|
FCF
-
|
|
Op. Margin
18.90%
|
Net Margin
10.80%
|
ROE
-
|
ROI
14.70%
|
|
ROA
-
|
EPS Growth
-39.70%
|
Current Ratio
5.6
|
Debt/Equity
32.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Pen Inc (PENC) | $1.20 | - | - | 3.7M | Strong Buy |
| Valeant Pharmaceuticals Intl I (VRX) | $14.15 | - | - | 5.95B | Strong Buy |
| Aralez Pharmaceuticals Inc (ARLZ) | $1.08 | - | - | 81.6M | Strong Buy |
| NovaBay Pharmaceuticals, Inc. (NBY) | $4.55 | - | - | 61.2M | Strong Buy |
| Palatin Technologies, Inc. (PTN) | $0.41 | - | - | 63M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
